Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8684-8697
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8684
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8684
Country | Number | Number | Prevalence | Number | Number | Co-infections |
of studies | of subjects | estimates | of studies | of HBoV+ subjects | estimates | |
(%) (95%CI) | (%) (95%CI) | |||||
Argentina | 4 | 1536 | 13.5 (11.8-15.3) | 4 | 208 | 55.8 (49.0-62.5) |
Australia | 10 | 2745 | 13.0 (11.7-14.2) | 3 | 132 | 64.4 (56.2-72.6) |
Belgium | 1 | 445 | 11.5 (8.5-14.4) | 1 | 51 | 49.0 (35.3-62.7) |
Brazil | 14 | 2718 | 10.8 (9.6-11.9) | 10 | 293 | 90.1 (86.7-93.5) |
Cambodia | 4 | 3779 | 1.6 (1.2-2.0) | 2 | 58 | 53.4 (40.6-66,3) |
Canada | 3 | 2825 | 4.1 (3.3-4.8) | 2 | 97 | 59.8 (50.0-69.6) |
China | 62 | 106960 | 5.0 (4.9-5.2) | 35 | 4088 | 50.3 (48.8-51.8) |
Denmark | 1 | 228 | 25.0 (19.4-30.6) | 1 | 57 | 47.4 (34.4-60.3) |
Egypt | 1 | 95 | 56.8 (46.9-66.8) | NG | NG | - |
Finland | 11 | 4541 | 6.3 (5.6-7.0) | 5 | 197 | 61.4 (54.6-68.2) |
France | 16 | 5826 | 6.1 (5.5-6.8) | 13 | 282 | 31.2 (25.8-36.6) |
Germany | 17 | 4595 | 10.1 (9.2-10.9) | 10 | 390 | 38.7 (33.9-43.6) |
Greece | 3 | 2039 | 5.8 (4.8-6.8) | 3 | 118 | 48.3 (39.3-57.3) |
Hong Kong | 3 | 3709 | 7.6 (6.7-8.4) | 1 | 95 | 18.9 (11.1-26.8) |
Hungary | 2 | 94 | 29.8 (20.5-39.0) | 1 | 28 | 53.6 (35.1-72.0) |
India | 2 | 605 | 4.0 (2.4-5.5) | 2 | 24 | 8.3 (0.0-19.4) |
Iran | 2 | 394 | 7.6 (5.0-10.2) | 1 | 21 | 33.3 (13.2-53.5) |
Israel | 2 | 721 | 4.0 (2.6-5.5) | 1 | 26 | 30.8 (13.0-48.5) |
Italy | 19 | 7354 | 7.4 (6.8-8.0) | 14 | 513 | 62.8 (58.6-67.0) |
Japan | 8 | 5016 | 10.1 (9.3-10.9) | 5 | 435 | 61.1 (56.6-65.7) |
Jordan | 1 | 312 | 18.3 (14.0-22.6) | 1 | 57 | 89.5 (81.5-97.4) |
Kenya | 1 | 384 | 1.8 (0.5-3.2) | 1 | 7 | 100.0 (-) |
Kuwait | 1 | 735 | 1.9 (0.9-2.9) | NG | NG | - |
Malawi | 1 | 95 | 6.3 (1.4-11.2) | NG | NG | - |
Mexico | 1 | 162 | 4.9 (1.6-8.3) | 1 | 8 | 37.5 (4.0-71.0) |
New Zealand | 1 | 230 | 3.5 (1.1-5.8) | 1 | 8 | 37.5 (4.0-71.0) |
Nicaragua | 1 | 192 | 33.3 (26.7-40.0) | NG | NG | - |
Nigeria | 1 | 246 | 2.4 (0.5-4.4) | 1 | 6 | 83.3 (53.5-100) |
Norway | 3 | 1853 | 12.0 (10.5-13.5) | 3 | 222 | 72.1 (66.2-78.0) |
Peru | 1 | 191 | 25.1 (19.0-31.3) | NG | NG | - |
Portugal | 3 | 428 | 6.5 (4.2-8.9) | NG | NG | - |
Senegal | 2 | 312 | 1.0 (0.0-2.0) | 2 | 3 | 33.3 (0.0-86.7) |
Shanghai | 1 | 486 | 24.5 (20.7-28.3) | 1 | 119 | 54.6 (45.7-63.6) |
Singapore | 1 | 500 | 8.0 (5.6-10.4) | 1 | 40 | 30.0 (15.8-44.2) |
Slovenia | 1 | 891 | 18.4 (15.9-21.0) | 1 | 164 | 59.8 (52.3-67.3) |
South Africa | 6 | 2880 | 10.3 (9.2-11.4) | 5 | 278 | 56.8 (51.0-62.7) |
South Arabia | 5 | 833 | 5.3 (3.8-6.8) | 4 | 39 | 53.8 (38.2-69.5) |
South Korea | 10 | 7594 | 5.8 (5.2-6.3) | 10 | 437 | 43.0 (38.4-47.7) |
Spain | 16 | 13560 | 9.9 (9.4-10.4) | 9 | 794 | 72.2 (69.0-75.3) |
Sweden | 3 | 956 | 12.1 (10.1-14.2) | 3 | 116 | 38.8 (29.9-47.7) |
Switzerland | 3 | 279 | 4.3 (1.9-6.7) | NG | NG | - |
Taiwan | 5 | 1657 | 5.6 (4.4-6.7) | 4 | 62 | 33.9 (22.1-45.7) |
Thailand | 8 | 2983 | 7.1 (6.2-8.0) | 2 | 40 | 62.5 (47.5-77.5) |
The Netherlands | 5 | 2645 | 6.8 (5.9-7.8) | 3 | 9 | 66.7 (35.9-97.5) |
The Philippines | 2 | 1284 | 1.0 (0.5-1.6) | 1 | 7 | 71.4 (38.0-100) |
Turkey | 10 | 3949 | 2.3 (1.8-2.8) | 4 | 39 | 30.8 (16.3-45.3) |
United Kingdom | 8 | 14923 | 1.5 (1.3-1.7) | 4 | 102 | 32.4 (23.3-41.4) |
Uruguay | 1 | 1078 | 4.1 (2.9-5.3) | 1 | 44 | 54.5 (39.8-69.3) |
United States | 21 | 13549 | 9.8 (9.3-10.3) | 14 | 903 | 38.1 (34.9-41.3) |
Vietnam | 3 | 2349 | 5.5 (4.6-6.4) | 2 | 128 | 45.3 (36.7-53.9) |
Total | 311 | 233761 | 6.3 (6.2-6.4) | 193 | 10745 | 52.4 (51.5-53.4) |
Country | Number | Number | Prevalence | Number | Number | Co-infections |
of studies | of subjects | estimates | of studies | of HBoV+ subjects | estimates | |
(% ) (95%CI) | (%) (95%CI) | |||||
Albania | 1 | 142 | 9.2 (4.4-13.9) | 1 | 13 | 23.1 (0.2-46.0) |
Australia | 3 | 890 | 8.5 (6.7-10.4) | NG | NG | - |
Bangladesh | 1 | 138 | 63.0 (55.0-71.1) | NG | NG | - |
Brazil | 5 | 2469 | 4.8 (4.0-5.7) | 5 | 119 | 15.1 (8.7-21.6) |
Chile | 1 | 462 | 19.3 (15.7-22.9) | NG | NG | - |
China | 16 | 8805 | 6.6 (6.1-7.1) | 8 | 380 | 67.4 (62.7-72.1) |
Finland | 3 | 2493 | 10.3 (9.1-11.5) | 2 | 251 | 32.7 (26.9-38.5) |
Germany | 2 | 338 | 8.3 (5.3-11.2) | 2 | 28 | 28.6 (11.8-45.3) |
Hong Kong | 1 | 1600 | 6.4 (5.2-7.6) | NG | NG | - |
Hungary | 1 | 61 | 3.3 (0.0-7.7) | NG | NG | - |
Iran | 4 | 621 | 14.2 (11.4-16.9) | 1 | 16 | 0.0 (0.0-0.0) |
Ireland | 1 | 155 | 7.7 (3.5-11.9) | 1 | 12 | 100.0 (100.0-100.0) |
Italy | 2 | 1291 | 2.8 (1.9-3.7) | 2 | 36 | 22.2 (8.6-35.8) |
Japan | 2 | 424 | 3.8 (2.0-5.6) | 2 | 16 | 62.5 (38.8-86.2) |
Mexico | 1 | 76 | 1.3 (0.0-3.9) | 1 | 1 | 100.0 (100.0-100.0) |
Nepal | 1 | 96 | 9.4 (3.5-15.2) | NG | NG | - |
Nigeria | 1 | 96 | 29.2 (20.1-38.3) | NG | NG | - |
Pakistan | 3 | 498 | 10.6 (7.9-13.4) | 1 | 47 | 97.9 (93.7-100.0) |
Paraguay | 1 | 349 | 10.6 (7.4-13.8) | 1 | 37 | 40.5 (24.7-56.4) |
Russia | 2 | 7031 | 1.4 (1.1-1.6) | 2 | 95 | 49.5 (39.4-59.5) |
South Korea | 3 | 1640 | 3.8 (2.9-4.8) | 2 | 55 | 14.5 (5.2-23.9) |
Spain | 1 | 520 | 9.2 (6.7-11.7) | 1 | 48 | 52.1 (38.0-66.2) |
Taiwan | 1 | 110 | 3.6 (0.1-7.1) | NG | NG | - |
Thailand | 4 | 848 | 3.8 (2.5-5.1) | 3 | 19 | 57.9 (35.7-80.1) |
Tunisia | 1 | 96 | 58.3 (48.5-68.2) | NG | NG | - |
Turkey | 1 | 150 | 8.7 (4.2-13.2) | NG | NG | - |
United Kingdom | 3 | 12459 | 5.4 (5.0-5.7) | 1 | 324 | 46.0 (40.6-51.4) |
United States | 2 | 640 | 3.6 (2.2-5.0) | NG | NG | - |
Total | 68 | 44498 | 5.9 (5.7-6.1) | 36 | 1497 | 46.7 (44.2-49.2) |
- Citation: Guido M, Tumolo MR, Verri T, Romano A, Serio F, De Giorgi M, De Donno A, Bagordo F, Zizza A. Human bocavirus: Current knowledge and future challenges. World J Gastroenterol 2016; 22(39): 8684-8697
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8684.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8684